Expansion of Telehealth Pharmacy Services in the Face of the COVID-19 Pandemic: Perspectives of a Preceptor and PGY2 Ambulatory Care Resident

Due to the COVID-19 pandemic, our pharmacotherapy clinic had to rapidly create new workflows for telehealth services to allow for continued care of our patients, while minimizing their possible exposure to COVID-19.  We will be discussing how we have rapidly converted our face-to-face pharmacist visits to telehealth visits to minimize patient exposure in the ambulatory care clinics, as well as, pharmacist/provider exposure to patients unnecessarily. In addition, we will discuss the types of telehealth visits provided, the roadblocks we have encountered/lessons learned and current reimbursement for such services.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.